Similar articles

• Prospective Evaluation of Ultrafast Breast MRI for Predicting Pathologic Response after Neoadjuvant Therapies.

  Ramtohul T, Tescher C, Vaflard P, Cyrta J, Girard N, Malhaire C, Tardivon A. Ramtohul T, et al. Radiology. 2022 Dec;305(3):565-574. doi: 10.1148/radiol.220389. Epub 2022 Jul 26. Radiology. 2022. PMID: 35880977
• The assessment of breast cancer response to neoadjuvant chemotherapy: comparison of magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography.

  Park JS, Moon WK, Lyou CY, Cho N, Kang KW, Chung JK. Park JS, et al. Acta Radiol. 2011 Feb 1;52(1):21-8. doi: 10.1258/ar.2010.100142. Acta Radiol. 2011. PMID: 21498321
• Ultrafast dynamic contrast-enhanced breast MRI: association with pathologic complete response in neoadjuvant treatment of breast cancer.

  Kim JH, Park VY, Shin HJ, Kim MJ, Yoon JH. Kim JH, et al. Eur Radiol. 2022 Jul;32(7):4823-4833. doi: 10.1007/s00330-021-08530-4. Epub 2022 Jan 22. Eur Radiol. 2022. PMID: 35064805
• Role of Magnetic Resonance Imaging in Detection of Pathologic Complete Remission in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy: A Meta-analysis.

  Gu YL, Pan SM, Ren J, Yang ZX, Jiang GQ. Gu YL, et al. Clin Breast Cancer. 2017 Jul;17(4):245-255. doi: 10.1016/j.clbc.2016.12.010. Epub 2017 Jan 11. Clin Breast Cancer. 2017. PMID: 28209330 Review.
• Imaging Neoadjuvant Therapy Response in Breast Cancer.

  Fowler AM, Mankoff DA, Joe BN. Fowler AM, et al. Radiology. 2017 Nov;285(2):358-375. doi: 10.1148/radiol.2017170180. Radiology. 2017. PMID: 29045232 Review.